Literature DB >> 24516070

Capgras' syndrome in first-episode psychotic disorders.

Paola Salvatore1, Chaya Bhuvaneswar, Mauricio Tohen, Hari-Mandir K Khalsa, Carlo Maggini, Ross J Baldessarini.   

Abstract

BACKGROUND: Misidentification phenomena, including the delusion of 'imposters' named after Joseph Capgras, occur in various major psychiatric and neurological disorders but have rarely been studied systematically in broad samples of modern patients. This study investigated the prevalence and correlated clinical factors of Capgras' phenomenon in a broad sample of patient-subjects with first-lifetime episodes of psychotic affective and nonaffective disorders.
METHODS: We evaluated 517 initially hospitalized, first-episode psychotic-disorder patients for the prevalence of Capgras' phenomenon and its association with DSM-IV-TR diagnoses including schizophreniform, brief psychotic, unspecified psychotic, delusional, and schizoaffective disorders, schizophrenia, bipolar-I disorder and major depression with psychotic features, and with characteristics of interest including antecedent psychiatric and neurological morbidity, onset type and presenting psychopathological phenomena, using standard bivariate and multivariate statistical methods.
RESULTS: Capgras' syndrome was identified in 73/517 (14.1%) patients (8.2-50% across diagnoses). Risk was greatest with acute or brief psychotic disorders (schizophreniform psychoses 50%, brief psychoses 34.8%, or unspecified psychoses 23.9%), intermediate in major depression (15%), schizophrenia (11.4%) and delusional disorder (11.1%), and lowest in bipolar-I (10.3%) and schizoaffective disorders (8.2%). Associated were somatosensory, olfactory and tactile hallucinations, Schneiderian (especially delusional perception), and cycloid features including polymorphous psychotic phenomena, rapidly shifting psychomotor and affective symptoms, pananxiety, ecstasy, overconcern with death, and perplexity or confusion, as well as rapid onset, but not sex, age, abuse history, dissociative features, or indications of neurological disorders.
CONCLUSIONS: Capgras' syndrome was prevalent across a broad spectrum of first-episode psychotic disorders, most often in acute psychoses of rapid onset.

Entities:  

Mesh:

Year:  2014        PMID: 24516070      PMCID: PMC4065173          DOI: 10.1159/000357813

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  55 in total

1.  Coexistence of Capgras and Frégoli syndromes in a single patient. Clinical, neuroimaging and neuropsychological findings.

Authors:  L Lykouras; M Typaldou; R Gournellis; G Vaslamatzis; G-N Christodoulou
Journal:  Eur Psychiatry       Date:  2002-07       Impact factor: 5.361

Review 2.  Delusional misidentification and the role of the right hemisphere in the appreciation of identity.

Authors:  J Cutting
Journal:  Br J Psychiatry Suppl       Date:  1991-11

3.  Clinical features of parricide in patients with schizophrenia.

Authors:  Byoung-Hoon Ahn; Jeong-Hyun Kim; Sohee Oh; Sang Sub Choi; Sung Ho Ahn; Sun Bum Kim
Journal:  Aust N Z J Psychiatry       Date:  2012-03-22       Impact factor: 5.744

Review 4.  [Cenesthopathies: a disorder of background emotions at the crossroads of the cognitive sciences and phenomenology].

Authors:  J Graux; M Lemoine; P Gaillard; V Camus
Journal:  Encephale       Date:  2010-12-03       Impact factor: 1.291

Review 5.  Delusional misidentifications: facts and fancies.

Authors:  I S Marková; G E Berrios
Journal:  Psychopathology       Date:  1994       Impact factor: 1.944

Review 6.  Fregoli syndrome.

Authors:  R Mojtabai
Journal:  Aust N Z J Psychiatry       Date:  1994-09       Impact factor: 5.744

7.  The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.

Authors:  Mauricio Tohen; Carlos A Zarate; John Hennen; Hari-Mandir Kaur Khalsa; Stephen M Strakowski; Priscilla Gebre-Medhin; Paola Salvatore; Ross J Baldessarini
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

8.  A continuum of misidentification symptoms.

Authors:  H N Sno
Journal:  Psychopathology       Date:  1994       Impact factor: 1.944

9.  The Capgras and Cotard delusions.

Authors:  A W Young; K M Leafhead; T K Szulecka
Journal:  Psychopathology       Date:  1994       Impact factor: 1.944

Review 10.  Cotard's syndrome: analysis of 100 cases.

Authors:  G E Berrios; R Luque
Journal:  Acta Psychiatr Scand       Date:  1995-03       Impact factor: 6.392

View more
  7 in total

1.  Reply: Capgras syndrome: neuroanatomical assessment of brain MRI findings in an adolescent patient.

Authors:  R Ryan Darby; Michael D Fox
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

2.  Serial killing in schizophrenia.

Authors:  Ghada Hamdi; Hanen Ben Ammar; Nawel Mhedhbi; Lina Brahmi; Rania Felhi; Rym Ridha
Journal:  Clin Case Rep       Date:  2022-06-02

3.  Capgras syndrome associated with limbic encephalitis in a patient with diffuse large B-cell lymphoma.

Authors:  Herval Ribeiro Soares; Wagner Cid Palmeira Cavalcante; Sebastião Nunes Martins; Jerusa Smid; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

4.  An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies.

Authors:  Paolo Solla; Gioia Mura; Antonino Cannas; Gianluca Floris; Davide Fonti; Gianni Orofino; Mauro Giovanni Carta; Francesco Marrosu
Journal:  BMC Neurol       Date:  2017-04-19       Impact factor: 2.474

5.  Aggressiveness, violence, homicidality, homicide, and Lyme disease.

Authors:  Robert C Bransfield
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-09       Impact factor: 2.570

6.  Capgras syndrome in substance-induced psychosis.

Authors:  Bharat R Sampathi; Anna Sofine; John Alvarez; Robert Bota
Journal:  Ment Illn       Date:  2018-11-06

7.  Cognitive neuropsychiatric analysis of an additional large Capgras delusion case series.

Authors:  Emily A Currell; Nomi Werbeloff; Joseph F Hayes; Vaughan Bell
Journal:  Cogn Neuropsychiatry       Date:  2019-02-22       Impact factor: 1.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.